Company · CIK 0001560241
G1 Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AG1 Therapeutics, Inc.0000935836-24-000655 · 67.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-221120 · 298.5 KBSEC(opens sec.gov)
- SC 13GG1 Therapeutics, Inc.0000935836-24-000538 · 69.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001628280-24-036149 · 6.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001628280-24-035854 · 2.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-195484 · 865.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001628280-24-029426 · 956.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001628280-24-028288 · 174.5 KBSEC(opens sec.gov)
- 10-QQuarterly update0001628280-24-019622 · 5.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001628280-24-019453 · 1.6 MBSEC(opens sec.gov)
Insiders
- Avagliano MarkChief Business Officer
- Bailey John E. (Jack) Jr.Director, President and CEO
- Deese Willie ADirector
- DEMAREE JOHNChief Commercial Officer
- ESHELMAN FREDRIC NDirector
- Eshelman Ventures, LLC10% Owner
- Flowers Cynthia LouiseDirector
- Gupta SomaChief Commercial Officer
- Hanson James S.General Counsel
- Hatteras Venture Advisors IV SBIC, LLC10% Owner
Tickers
No tickers on record.
Addresses
business
700 PARK OFFICES DRIVE SUITE 200
RESEARCH TRIANGLE PARK, NC, 27709
mailing
700 PARK OFFICES DRIVE SUITE 200
RESEARCH TRIANGLE PARK, NC, 27709
Former names
- G-Zero Therapeutics, Inc.2013-04-18
Same industry